Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

SELL
$155.22 - $162.74 $62,553 - $65,584
-403 Reduced 20.75%
1,539 $243,000
Q4 2023

Feb 01, 2024

SELL
$145.6 - $158.88 $225,825 - $246,422
-1,551 Reduced 44.4%
1,942 $304,000
Q3 2023

Oct 25, 2023

BUY
$155.75 - $174.48 $180,825 - $202,571
1,161 Added 49.79%
3,493 $544,000
Q2 2023

Jul 18, 2023

BUY
$154.35 - $166.11 $359,944 - $387,368
2,332 New
2,332 $385,000
Q4 2022

Jan 26, 2023

BUY
$160.2 - $179.79 $434,782 - $487,950
2,714 Added 52.63%
7,871 $0
Q3 2022

Nov 07, 2022

SELL
$161.33 - $179.52 $10,970 - $12,207
-68 Reduced 1.3%
5,157 $843,000
Q2 2022

Jul 20, 2022

BUY
$168.19 - $186.01 $334,698 - $370,159
1,990 Added 61.51%
5,225 $928,000
Q1 2022

Apr 14, 2022

SELL
$158.14 - $179.59 $69,265 - $78,660
-438 Reduced 11.92%
3,235 $573,000
Q4 2021

Jan 18, 2022

BUY
$155.93 - $173.01 $65,802 - $73,010
422 Added 12.98%
3,673 $628,000
Q3 2021

Oct 22, 2021

BUY
$161.5 - $179.47 $67,184 - $74,659
416 Added 14.67%
3,251 $525,000
Q2 2021

Jul 27, 2021

BUY
$159.48 - $171.07 $452,125 - $484,983
2,835 New
2,835 $467,000
Q1 2019

Apr 10, 2019

SELL
$125.72 - $139.79 $207,563 - $230,793
-1,651 Closed
0 $0
Q4 2018

Jan 15, 2019

SELL
$122.84 - $147.84 $122 - $147
-1 Reduced 0.06%
1,651 $213,000
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $192,704 - $226,464
1,585 Added 2365.67%
1,652 $228,000
Q3 2018

Oct 11, 2018

SELL
$121.58 - $142.88 $22,613 - $26,575
-186 Reduced 73.52%
67 $9,000
Q2 2018

Jul 17, 2018

SELL
$119.4 - $131.76 $31,282 - $34,521
-262 Reduced 50.87%
253 $31,000
Q1 2018

Apr 17, 2018

BUY
$125.1 - $148.14 $125 - $148
1 Added 0.19%
515 $64,000
Q4 2017

Feb 05, 2018

BUY
$131.22 - $143.62 $67,447 - $73,820
514
514 $71,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Monument Capital Management Portfolio

Follow Monument Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monument Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Monument Capital Management with notifications on news.